Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth vs Franklin India Technology Fund-Growth
Side-by-side comparison of NAV, returns, expense ratio and star rating.
TopFund Analysis
Based on the provided metrics, Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth appears stronger due to its higher returns across all timeframes, notably a 1Y return of 19.04% and a 3Y CAGR of 21.72%, compared to Franklin India Technology Fund-Growth's negative 1Y return of -5.8%. However, Franklin India Technology Fund has a higher star rating of 5 compared to Aditya Birla's 3, indicating a better overall assessment by analysts, albeit with a higher expense ratio of 1.16%. Investors should consider the tradeoff between Aditya Birla's superior returns and Franklin's higher rating when making their choice.
Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth
Aditya Birla Sun Life Mutual Fund
★★★★★
Equity · Sectoral
Franklin India Technology Fund-Growth
Franklin Templeton Mutual Fund
★★★★★
Equity · Sectoral
| Metric | Aditya Birla Sun Life ... | Franklin India Technol... |
|---|---|---|
| NAV | ₹40.76 | ₹544.36 |
| Star Rating | ★★★ | ★★★★★ |
| Expense Ratio | 1.04% | 1.16% |
| AUM | ₹1,077 Cr | ₹1,742 Cr |
| 1M Return | +3.11% | +5.45% |
| 3M Return | +0.32% | -0.29% |
| 6M Return | +12.07% | +13.03% |
| 1Y Return | +19.04% | -5.8% |
| 3Y CAGR | +21.72% | +10.29% |
| 5Y CAGR | +15.52% | +7.22% |
| Risk Level | — | — |
| Fund Manager | Dhaval Shah | Anand Radhakrishnan, Srikesh Nair, Varun Sharma |